The partnership is realized in the context of a cross-functional, product-oriented effort to provide statistical expertise and consultation for all key MHI or HTA business activities, including but are not limited to Medical Affairs research proposal reviews, strategic planning and input on TA strategies, real world evidence (RWE) study designs, real world database (RWD) research, scientific presentations and publications for all therapeutic areas, vendor oversight of study executions, RWE methodology research, and evidence evaluations and generations for HTA submissions. In collaboration with MHI, Clinical Statistics, Data Sciences, Statistical Programming and other stakeholders to evaluate existing databases, both clinical studies and real-world databases, conduct feasibility assessment to identify fit-for-purpose data sources for research questions, and develop detailed and actionable analysis plans for evidence generation to deliver high quality, patient-centric evidence and insights to drive decisions.